ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Paul S. Brown, Jr
Fred W. Holland
Gary L. Parenteau
Richard E. Clark
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, P. S.
Right arrow Articles by Clark, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, P. S., Jr
Right arrow Articles by Clark, R. E.

Ann Thorac Surg 1991;51:359-367
© 1991 The Society of Thoracic Surgeons


Articles

Magnesium ion is beneficial in hypothermic crystalloid cardioplegia

Paul S. Brown, Jr, MD1, Fred W. Holland, MD, Gary L. Parenteau, MD, Richard E. Clark, MD*

Surgery Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland USA

* Address reprint requests to Dr Clark, Department of Surgery, Allegheny General Hospital, 320 North Ave, Pittsburgh, PA 15212.

The role of magnesium ion and its relation to the calcium concentration of cardioplegic solutions was reexamined in this study. Isolated rat hearts were used with an oxygenated modified Krebs-Henseleit bicarbonate buffer as perfusion medium. The hearts were arrested for 20 minutes at 37 °C or 90 minutes at 24 °C. Treatment groups received one dose of nine possible cardioplegic solutions containing magnesium (0, 1.2, or 15 mmol/L) and calcium (0.05, 1.5, or 4.5 mmol/L). Ninety-six percent of the 75 magnesium-treated hearts recovered, regardless of the calcium concentration, in contrast to a 52% recovery rate in the 69 hearts that did not receive magnesium. The addition of 15 mmol/L Mg2+ to a cardioplegic solution containing no magnesium but 0.05 mmol/L Ca2+ significantly increased (p < 0.01) the percent recovery of the following parameters of cardiac function: systolic pressure, 74% to 93% (37 °C), 64% to 98% (24 °C); cardiac output, 76% to 101% (37 °C), 71% to 102% (24 °C); stroke work, 64% to 104% (37 °C), 52% to 99% (24 °C); and adenosine triphosphate level, 75% to 83% (37 °C), 58% to 90% (24 °C). There were significant reductions (p < 0.03) in percent recovery (37 °C and 24 °C) of cardiac output, stroke work, and adenosine triphosphate level in the groups that contained 0 or 15 mmol/L Mg2+ as the calcium concentration was increased from 0.05 to 4.5 mmol/L. Significant progressive augmentation of ventricular recovery and decreased overall mortality is produced at 37 ° and 24 °C with cardioplegia containing high levels of magnesium and low levels of calcium. These data demonstrate the importance of the [equation] relation in an oxygenated crystalloid solution with a pH of 7.45, carbon dioxide tension of 40 mm Hg, and oxygen tension of 750 mm Hg containing 142 mmol/L Na+.




This article has been cited by other articles:


Home page
Interact CardioVasc Thorac SurgHome page
Y. Maruyama and D. J. Chambers
Myocardial protection: efficacy of a novel magnesium-based cardioplegia (RS-C) compared to St Thomas' Hospital cardioplegic solution
Interact CardioVasc Thorac Surg, October 1, 2008; 7(5): 797 - 797.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
J. An, A. K. S. Camara, Q. Chen, and D. F. Stowe
Effect of low [CaCl2] and high [MgCl2] cardioplegia and moderate hypothermic ischemia on myoplasmic [Ca2+] and cardiac function in intact hearts
Eur J Cardiothorac Surg, December 1, 2003; 24(6): 974 - 985.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Bosteels, P. Matejovic, W. Flameng, and K. Mubagwa
Sodium influx via a non-selective pathway activated by the removal of extracellular divalent cations: possible role in the calcium paradox
Cardiovasc Res, August 1, 1999; 43(2): 417 - 425.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. Storm and J. J. Zimmerman
Magnesium Deficiency and Cardiogenic Shock After Cardiopulmonary Bypass
Ann. Thorac. Surg., August 1, 1997; 64(2): 572 - 577.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. S. Sett, H. Tearle, and J. G. LeBlanc
EFFECT OF GLUTAMATE-ASPARTATE REPERFUSION ON POSTISCHEMIC NEONATAL MYOCARDIUM
J. Thorac. Cardiovasc. Surg., March 1, 1997; 113(3): 462 - 466.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
J. C. Cleveland Jr, D. R. Meldrum, R. T. Rowland, A. Banerjee, and A. H. Harken
Optimal Myocardial Preservation: Cooling, Cardioplegia, and Conditioning
Ann. Thorac. Surg., February 1, 1996; 61(2): 760 - 768.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
J. Caspi, E. Rudis, I. Bar, T. Safadi, and M. Saute
Effects of magnesium on myocardial function after coronary artery bypass grafting
Ann. Thorac. Surg., April 1, 1995; 59(4): 942 - 947.
[Abstract] [PDF]


Home page
CirculationHome page
M. J. Taylor, J. E. Bailes, A. M. Elrifai, S.-R. Shih, E. Teeple, M. L. Leavitt, J. G. Baust, and J. C. Maroon
A New Solution for Life Without Blood : Asanguineous Low-Flow Perfusion of a Whole-Body Perfusate During 3 Hours of Cardiac Arrest and Profound Hypothermia
Circulation, January 15, 1995; 91(2): 431 - 444.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
J. C. Stringham, K. L. Paulsen, J. H. Southard, R. M. Mentzer Jr, and F. O. Belzer
Forty-hour preservation of the rabbit heart: Optimal osmolarity, [Mg2+], and pH of a modified UW solution
Ann. Thorac. Surg., July 1, 1994; 58(1): 7 - 13.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. Takemoto, H. Kuroda, T. Hamasaki, Y. Hara, S. Ishiguro, and T. Mori
Effect of magnesium and calcium on myocafdial protection by cardioplegic solutions
Ann. Thorac. Surg., January 1, 1994; 57(1): 177 - 182.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. Menasche, J.-P. Fleury, L. Veyssie, O. Le Dref, B. Touchot, A. H. Piwnica, and B. Gerard
Limitation of vasodilation associated with warm heart operation by a "mini-cardioplegia" delivery technique
Ann. Thorac. Surg., November 1, 1993; 56(5): 1148 - 1153.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1991 by The Society of Thoracic Surgeons.